Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Paranhos
Augusto
A
Hospital Israelita Albert Einstein, São Paulo, Brazil. augusto.paranhos@uol.com.br
Mendonça
Marcelo
M
Silva
Marcelo Jordão
MJ
Giampani
Jair
J
Torres
Rogério João Almeida
RJ
Della Paolera
Mauricio
M
Russ
Heloisa
H
Lottenberg
Claudio Luiz
CL
D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000069580:Bimatoprost; D003008:Cloprostenol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D005500:Follow-Up Studies; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced* / Q000453:epidemiology; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D008137:Longitudinal Studies; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000069557:Travoprost
D000577:Amides; D000959:Antihypertensive Agents; D004338:Drug Combinations; D011461:Prostaglandins F, Synthetic; D003008:Cloprostenol; D000077338:Latanoprost; D013999:Timolol; D000069580:Bimatoprost; D000069557:Travoprost